Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
(R)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide is an impurity of Bortezomib (B675700); the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
您的位置：
